Enrolling and retaining mothers of substance-exposed infants in drug abuse treatment

J Consult Clin Psychol. 2003 Aug;71(4):764-72. doi: 10.1037/0022-006x.71.4.764.

Abstract

This study provided an experimental test of a drug abuse treatment enrollment and retention intervention in a sample of 103 Black mothers of substance-exposed infants. Significantly more women assigned to the Engaging Moms Program enrolled into drug abuse treatment than did women assigned to the control condition (88% vs. 46%). Sixty-seven percent of participants in the Engaging Moms Program received at least 4 weeks of drug abuse treatment compared with 38% of the control women. However, there were no differences between the groups 90 days following treatment entry. Logistic regressions revealed that readiness for treatment predicted both short-term and long-term treatment retention. The Engaging Moms Program has considerable promise in facilitating treatment entry and short-term retention, but it did not influence long-term retention.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Female
  • Humans
  • Infant
  • Mothers*
  • Motivation*
  • Patient Compliance / statistics & numerical data*
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Substance-Related Disorders / therapy*